A review of the use of adapalene for the treatment of acne vulgaris
- PMID: 18472984
- PMCID: PMC2374937
A review of the use of adapalene for the treatment of acne vulgaris
Abstract
Acne is a disease of the pilosebaceous unit with involving abnormalities in sebum production, microbial flora changes, abnormal keratinization, and inflammation. There are several therapeutic options like topical and systemic retinoids, antibiotics, and systemic hormonal drugs. The topical retinoids a play very important role in the treatment of acne vulgaris. However, their use is limited due to skin irritation. A new generation product, adapalene is a good choice in the treatment of acne vulgaris with less side effects and high efficacy confirmed by numerous clinical studies.
Keywords: acne vulgaris; adapalene; treatment.
Similar articles
-
A review of the use of combination therapies for the treatment of acne vulgaris.J Am Acad Dermatol. 2003 Sep;49(3 Suppl):S200-10. doi: 10.1067/s0190-9622(03)01154-x. J Am Acad Dermatol. 2003. PMID: 12963896 Review.
-
A review of adapalene in the treatment of acne vulgaris.J Adolesc Health. 2008 Nov;43(5):421-4. doi: 10.1016/j.jadohealth.2008.06.005. J Adolesc Health. 2008. PMID: 18848668 Review.
-
Topical Retinoids in Acne Vulgaris: A Systematic Review.Am J Clin Dermatol. 2019 Jun;20(3):345-365. doi: 10.1007/s40257-019-00423-z. Am J Clin Dermatol. 2019. PMID: 30674002
-
Selective RAR agonists for acne vulgaris: A narrative review.J Cosmet Dermatol. 2020 Jun;19(6):1278-1283. doi: 10.1111/jocd.13340. Epub 2020 Feb 26. J Cosmet Dermatol. 2020. PMID: 32100454 Review.
-
Increase adapalene delivery using chemical and herbal enhancers.J Cosmet Dermatol. 2021 Sep;20(9):3011-3017. doi: 10.1111/jocd.13960. Epub 2021 Feb 2. J Cosmet Dermatol. 2021. PMID: 33528091
Cited by
-
Letter to the editor: comparative efficacy and safety of clindamycin phosphate/benzoyl peroxide and adapalene/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials.Arch Dermatol Res. 2024 Sep 3;316(8):595. doi: 10.1007/s00403-024-03346-w. Arch Dermatol Res. 2024. PMID: 39225838 No abstract available.
-
Formulation and evaluation of Adapalene-loaded nanoparticulates for epidermal localization.Drug Deliv Transl Res. 2015 Dec;5(6):585-95. doi: 10.1007/s13346-015-0261-z. Drug Deliv Transl Res. 2015. PMID: 26483036
-
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.Clin Drug Investig. 2017 Nov;37(11):1083-1091. doi: 10.1007/s40261-017-0568-2. Clin Drug Investig. 2017. PMID: 28913735 Clinical Trial.
-
The efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: a pilot study.Indian J Dermatol. 2015 Jan-Feb;60(1):103. doi: 10.4103/0019-5154.147838. Indian J Dermatol. 2015. PMID: 25657419 Free PMC article.
-
Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness.Drug Des Devel Ther. 2022 Nov 4;16:3847-3864. doi: 10.2147/DDDT.S383051. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36388080 Free PMC article.
References
-
- Bergfeld WF. The evolving role of retinoids in the management of cutaneous conditions. Clinician. 1998;16:1–32.
-
- Bershad S, Kranjac Singer GK, Parente JE, et al. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002;138:481–9. - PubMed
-
- Brand B, Gilbert R, Baker MD, et al. Cumulative irritancy comparision of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol. 2003;49:S227–32. - PubMed
-
- Braun-Falco O, Plewig G, Wolff HH, et al. Dermatology. 2. Berlin: Springer-Verlag; 2001.
-
- Cunliffe WJ, Caputo R, Dreno B, et al. Clinical efficacy and safety comparision of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol. 1997;36:S126–34. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources